These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1487 related articles for article (PubMed ID: 9301701)
1. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate. Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701 [TBL] [Abstract][Full Text] [Related]
2. DNA ploidy and proliferation heterogeneity in human prostate cancers. Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053 [TBL] [Abstract][Full Text] [Related]
4. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study. Strang P; Stenkvist B; Bergström R; Stendahl U; Valdes del Campo M; Tribukait B Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334 [TBL] [Abstract][Full Text] [Related]
5. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects. Forsslund G; Nilsson B; Zetterberg A Cancer; 1996 Oct; 78(8):1748-55. PubMed ID: 8859188 [TBL] [Abstract][Full Text] [Related]
6. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. Baldetorp B; Fernö M; Fallenius A; Fallenius-Vecchi G; Idvall I; Olsson H; Sigurdsson H; Akerman M; Killander D Cytometry; 1992; 13(6):577-85. PubMed ID: 1451590 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of DNA ploidy combined with a cytometric proliferation index of imprints from core needle biopsies in prostate cancer. Ahlgren G; Falkmer U; Gadaleanu V; Abrahamsson PA Eur Urol; 1999 Oct; 36(4):314-9. PubMed ID: 10473991 [TBL] [Abstract][Full Text] [Related]
8. [The clinical usefulness of flow cytometric DNA analysis in prostatic cancer]. Ishikawa A Hinyokika Kiyo; 1992 Jun; 38(6):665-70. PubMed ID: 1632320 [TBL] [Abstract][Full Text] [Related]
9. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis. Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238 [TBL] [Abstract][Full Text] [Related]
10. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients. Dreinhöfer KE; Baldetorp B; Akerman M; Fernö M; Rydholm A; Gustafson P Cytometry; 2002 Feb; 50(1):19-24. PubMed ID: 11857594 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma. Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434 [TBL] [Abstract][Full Text] [Related]
12. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate. Meyer JS; Gersell DJ; Yim S Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140 [TBL] [Abstract][Full Text] [Related]
13. [Significance of ploidy in prostatic cancer, quantified by a prospectively applicable procedure]. Valle Gerhold J; Azua Blanco J; Villarroya Rodríguez S; Romero Casabona P Arch Esp Urol; 1996 Mar; 49(2):139-45. PubMed ID: 8702324 [TBL] [Abstract][Full Text] [Related]
14. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix. Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420 [TBL] [Abstract][Full Text] [Related]
15. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix. Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380 [TBL] [Abstract][Full Text] [Related]
16. Alteration of DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer. Lammering G; Taher MM; Gruenagel HH; Borchard F; Porschen R Clin Cancer Res; 2000 Aug; 6(8):3215-21. PubMed ID: 10955806 [TBL] [Abstract][Full Text] [Related]
17. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas. Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696 [TBL] [Abstract][Full Text] [Related]
18. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis. Larsson P Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395 [TBL] [Abstract][Full Text] [Related]
19. DNA quantitation by image analysis of paraffin-embedded colorectal adenocarcinomas and its prognostic value. Bosari S; Lee AK; Wiley BD; Heatley GJ; Hamilton WM; Silverman ML Mod Pathol; 1992 May; 5(3):324-8. PubMed ID: 1495937 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of DNA ploidy status in patients with rectal cancer. Berczi C; Bocsi J; Bartha I; Math J; Balazs G Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]